Atlas Trials

Phase II Trial With Correlative Laboratory Studies of Single Agent Irinotecan (Camptosar CPT-11)

Clinical trial NCT00005626 · COMPLETED

Trial details

NCT number
NCT00005626
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
LeukemiaLymphoma
Start date
1998-02-01
Primary completion
2003-11-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.